A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus

• Asıl Yazarlar: Shuo Zhang (Yazar), Nan Jiang (Yazar), Li Wang (Yazar), Li Zhang (Yazar), Hua Chen (Yazar), Mengtao Li (Yazar), Xiaofeng Zeng (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SAGE Publishing, 2021-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Severe and refractory immune thrombocytopenia (ITP) affects the life expectancy of patients with systemic lupus erythematosus (SLE) and poses a challenge in their clinical management. This intervention study employed a small sample size to evaluate the efficacy and safety of a modified l...